Cuprina Holdings (Cayman) Limited (CUPR) Fair Value 2026

CUPR · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-08-28, Cuprina Holdings (Cayman) Limited (CUPR) trades at $3.01, versus a $1.11 median fair value across its 2 active models — 63.2% below the current price. QOC: 5.6/10. Value Trap Risk: 19/100 (SAFE). 2/13 models active.

Key Facts

Ticker
CUPR
Price
$3.01
Quality Score
5.6/10
Value Trap Risk
19/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Cuprina Holdings (Cayman) Limited (CUPR) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Cuprina Holdings (Cayman) Limited (CUPR) appears overvalued as of : the median of 2 independent fair value estimates is $1.11, 63.2% below the current price of $3.01. Estimates range from $0.93 to $1.29. CUPR scores 5.6/10 on fundamental quality and 19/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. CUPR’s -63.2% gap is wider than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Cuprina Holdings (Cayman) Limited Stock in 2026? →

What Fair Value Does Each Model Give CUPR?

2 Intrinsic Value Models vs. Current Price ($3.01)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.93 -69.1%
Asset-Based · Medium Conviction
 $1.29 -57.2%

All Models Active

All 2 models are displayed above.

What Is Cuprina Holdings (Cayman) Limited (CUPR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Cuprina Holdings (Cayman) Limited's intrinsic value is estimated at $1.11. Trading at its current price of $3.01, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -63.2%.

What Do the Models Say About CUPR?

2 of 13 models are currently active for CUPR. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for CUPR is $1.11 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does CUPR Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, CUPR ranks #43 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Cuprina Holdings (Cayman) Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CUPR a Value Trap?

CirclFi's Value Trap algorithm assigns CUPR a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Cuprina Holdings (Cayman) Limited. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Cuprina Holdings (Cayman) Limited earns a quality score of 5.6/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

Models cluster within a tight range (+11.8% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CUPR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CUPR's 2 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Cuprina Holdings (Cayman) Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

10 related Medical Instruments & Supplies stocks with 13-model coverage

HBIOHarvard Bioscience, Inc.QOC 5.8NYXHNyxoah SAQOC 5.6BNGOBionano Genomics, Inc.QOC 5.8LUCYLucyd, IncQOC 5.6KMTSKestra Medical Technologies, Ltd.QOC 5.8FEMYFemasys Inc.QOC 5.6ISRGIntuitive Surgical, Inc.QOC 9.4PDEXPro-Dex, Inc.QOC 7.8AVTRAvantor, Inc.QOC 6.5RMDResMed Inc.QOC 9.4

Read investment analysis: HBIO · NYXH · BNGO · LUCY · KMTS · FEMY · ISRG · PDEX · AVTR · RMD

Which Other Stocks Have a Similar Quality Score to CUPR?

7 companies across all industries closest to CUPR’s Quality of Company score of 5.6/10.

UPBUpstream Bio, Inc.QOC 5.6CTEVClaritev CorporationQOC 5.6ROIVRoivant Sciences Ltd.QOC 5.6WULFTeraWulf Inc.QOC 5.6XRXXerox Holdings CorporationQOC 5.6ACREAres Commercial Real Estate CorporationQOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: UPB · CTEV · ROIV · WULF · XRX · ACRE · NVDA

Where Does CUPR Sit in CirclFi's Medical Instruments & Supplies Rankings?

CUPR is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Cuprina Holdings (Cayman) Limited’s Valuation?

What is Cuprina Holdings (Cayman) Limited's intrinsic value in 2026?

CirclFi puts Cuprina Holdings (Cayman) Limited (CUPR)'s intrinsic value at $1.11 — the median of 2 independent model estimates as of 2026-08-28, ranging from $0.93 to $1.29. The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CUPR overvalued or undervalued right now?

At $3.01, 0 of 2 active models suggest CUPR may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $1.11, 63.2% below the current price of $3.01 — a consensus view that CUPR is overvalued. The assessment depends on which methodology best fits Cuprina Holdings (Cayman) Limited's business model in Medical Instruments & Supplies.

What does a Quality of Company score of 5.6 mean for CUPR?

Cuprina Holdings (Cayman) Limited's QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CUPR?

CirclFi analyzes CUPR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is CUPR a value trap in 2026?

Cuprina Holdings (Cayman) Limited's Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Cuprina Holdings (Cayman) Limited (CUPR) has a median fair value of $1.11 — 63.2% below the current price of $3.01 — as of 2026-08-28.” Source: circlfi.com/stock/CUPR/ · Methodology
Primary sources for this CUPR valuation
  • Financial statements: Cuprina Holdings (Cayman) Limited 10-K and 10-Q filings on SEC EDGAR (CIK 0001995704) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CUPR as of ; valuations recomputed .